КОІНФЕКЦІЯ ВІРУСУ ГЕПАТИТУ C ТА ВІРУСУ ІМУНОДЕФІЦИТУ ЛЮДИНИ, ПРОФІЛАКТИКА ТА СУЧАСНІ ПІДХОДИ ДО ЛІКУВАННЯ

Polina Kovalenco; Siuzanna Kots; Olena Raksha-Slyusareva; Alexey Slyusarev; Vitalii Kots

doi:10.30890/2567-5273.2025-39-04-044

Authors

Polina Kovalenco Donetsk National Medical University https://orcid.org/0000-0003-4731-6902
Siuzanna Kots G.S. Skovoroda Kharkiv National Pedagogical University https://orcid.org/0000-0001-5016-7181
Olena Raksha-Slyusareva Donetsk National Medical University https://orcid.org/0000-0003-2144-6792
Alexey Slyusarev Donetsk National Medical University https://orcid.org/0000-0002-2968-9388
Vitalii Kots G.S. Skovoroda Kharkiv National Pedagogical University https://orcid.org/0000-0001-5365-9608

DOI:

https://doi.org/10.30890/2567-5273.2025-39-04-044

Keywords:

hepatitis C, HIV, co-infection, antiviral therapy, treatment

Abstract

Hepatitis C in people living with HIV is a significant medical problem because co-infection leads to faster liver damage, increases the likelihood of developing cirrhosis and liver failure, and complicates the treatment process. The article examines the p

References

World Health Organization (WHO) (n.d.). Recommendations for diagnosis and treatment of hepatitis C. [online] Available at: [https://www.who.int] (https://www.who.int) [Accessed 17 Jun. 2025].

Ministry of Health of Ukraine (n.d.). National clinical protocols for the treatment of viral hepatitis C and HIV infection. [online] Available at: [https://moz.gov.ua] (https://moz.gov.ua) [Accessed 17 Jun. 2025].

European AIDS Clinical Society (EACS) (2023). Guidelines for the treatment of HIV and HCV co-infection. Version 11.1. [online] Available at: [https://www.eacsociety.org] (https://www.eacsociety.org) [Accessed 17 Jun. 2025].

American Association for the Study of Liver Diseases (AASLD) (n.d.) HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C. [online] Available at: [https://www.hcvguidelines.org] (https://www.hcvguidelines.org) [Accessed 17 Jun. 2025].

Terrault, N.A. and Hassanein, T. (2022). Management of Hepatitis C in HIV-Infected Patients, The New England Journal of Medicine, 387(21), pp. 1950–1961. doi:10.1056/NEJMra2206611.

Rockstroh, J.K., Bhagani, S., Benhamou, Y. et al. (2023). European consensus guidelines on the management of hepatitis C virus infection in HIV-infected patients: 2023 update, Clinical Infectious Diseases, 76(2), pp. 255–267. doi:10.1093/cid/ciac853.

Gural, A.L. and Soroka, Y.V. (2023). Hepatitis C in HIV-infected patients: features of the course and treatment, Infectious Diseases, 1(35), pp. 45–52. doi:10.15407/infectdis2023.01.045.

Roitt, I., Brostoff, J. and Male, D. (2000). Immunology. Translated from English. 592 pp.

Semenenko, T.A. (2000). Cellular immune response in hepatitis C, Information Bulletin “Viral Hepatitis”, (1), pp. 3–9.

Telegin, D.E., Gerasun, B.A., Vorozhbyt, O.B. et al. (2001). Humoral immune response to structural and non-structural proteins of the hepatitis C virus in different variants of the activity of the infectious process, in Viral hepatitis with parenteral mechanism of transmission of pathogens and their outcomes. Kyiv, pp. 141–146.